OGI OrganiGram
- 1.8400
- 0.00000.00%
OrganiGram News
Cannabis Stocks Drop as DEA Sets Drug-rescheduling Hearing After November Election
The hearing on the reclassification of cannabis is approaching, and both US cannabis stocks and ETFs are under pressure.
The upcoming open hearing on December 2nd by the US Drug Enforcement Administration has attracted widespread attention from the market, and aims to discuss the proposal to reclassify marijuana.
DEA Sets Hearing on Cannabis Rescheduling and Delays Decision Until After the Election
Cannabis Sales In Canada Decline Sharply: What's Behind The Drop?
Key Cannabis Leaders Gather For Networking At Benzinga's Fall 2024 Conference: The Last Big Event Before The Election
CEO Shake-Ups At Canopy, Curaleaf And Recent Top Exec And Board Changes In Cannabis And Psychedelics
CCORF Maintains OrganiGram(OGI.US) With Buy Rating, Raises Target Price to $2.62
Organigram Holdings Inc. Is Maintained at Speculative Buy by Canaccord Genuity
Organigram Holdings Inc. Price Target Raised to C$3.60/Share From C$3.25 by Canaccord Genuity
Canada Net Change Percentage Gainers & Losers
Cannabis Stock Movers For August 13, 2024
Toronto Stocks Advance; OrganiGram Holdings Up on 3Q Revenue Beat
Organigram (OGI) Q3 2024 Earnings Call Transcript
Earnings Call: Organigram Posts Growth and Efficiency Gains in Q3 2024
Earnings Call Summary | OrganiGram(OGI.US) Q3 2024 Earnings Conference
Express News | Organigram Shares Are Trading Higher After the Company Reported Better-than-expected Q3 Revenue Results
Organigram Holdings Inc. (OGI) Q3 2024 Earnings Call Transcript
OrganiGram's Stock Rises as Canadian Pot Company's Revenue Tops Analyst Estimate
OrganiGram | 6-K: Report of foreign private issuer (related to financial reporting)
Organigram Up 4.9% in U.S. Premarket After Q3 Profit Figures Released
Analysis
Price Target
No Data
